Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) Sees Significant Increase in Short Interest

Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) was the recipient of a significant increase in short interest in the month of February. As of February 15th, there was short interest totalling 181,600 shares, an increase of 18,060.0% from the January 31st total of 1,000 shares. Based on an average daily trading volume, of 50,287,400 shares, the short-interest ratio is currently 0.0 days.

Therapeutic Solutions International Price Performance

Shares of TSOI stock opened at $0.00 on Friday. Therapeutic Solutions International has a 1-year low of $0.00 and a 1-year high of $0.00.

About Therapeutic Solutions International

Therapeutic Solutions International, Inc focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production.